Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb EBITDA 2010-2023 | BMY

Bristol Myers Squibb annual and quarterly EBITDA history from 2010 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Bristol Myers Squibb EBITDA for the quarter ending June 30, 2023 was $4.291B, a 5.51% decline year-over-year.
  • Bristol Myers Squibb EBITDA for the twelve months ending June 30, 2023 was $18.667B, a 2.94% increase year-over-year.
  • Bristol Myers Squibb 2022 annual EBITDA was $17.989B, a 4.23% decline from 2021.
  • Bristol Myers Squibb 2021 annual EBITDA was $18.784B, a 435.31% increase from 2020.
  • Bristol Myers Squibb 2020 annual EBITDA was $3.509B, a 47.79% decline from 2019.
  
Bristol Myers Squibb Annual EBITDA
(Millions of US $)
2022 $17,989
2021 $18,784
2020 $3,509
2019 $6,721
2018 $6,605
2017 $5,920
2016 $6,297
2015 $2,453
2014 $2,848
2013 $3,654
2012 $5,143
2011 $7,609
2010 $6,678
2009 $6,027
Bristol Myers Squibb Quarterly EBITDA
(Millions of US $)
2023-06-30 $4,291
2023-03-31 $5,199
2022-12-31 $4,380
2022-09-30 $4,797
2022-06-30 $4,541
2022-03-31 $4,271
2021-12-31 $4,437
2021-09-30 $4,884
2021-06-30 $4,265
2021-03-31 $5,198
2020-12-31 $-7,761
2020-09-30 $4,912
2020-06-30 $4,185
2020-03-31 $2,173
2019-12-31 $1,107
2019-09-30 $1,520
2019-06-30 $1,945
2019-03-31 $2,149
2018-12-31 $1,677
2018-09-30 $2,332
2018-06-30 $674
2018-03-31 $1,922
2017-12-31 $895
2017-09-30 $1,371
2017-06-30 $1,506
2017-03-31 $2,148
2016-12-31 $1,208
2016-09-30 $1,664
2016-06-30 $1,705
2016-03-31 $1,720
2015-12-31 $-334
2015-09-30 $1,092
2015-06-30 $143
2015-03-31 $1,552
2014-12-31 $43
2014-09-30 $1,120
2014-06-30 $483
2014-03-31 $1,202
2013-12-31 $1,050
2013-09-30 $998
2013-06-30 $719
2013-03-31 $887
2012-12-31 $1,004
2012-09-30 $766
2012-06-30 $1,207
2012-03-31 $2,166
2011-12-31 $1,863
2011-09-30 $1,853
2011-06-30 $1,974
2011-03-31 $1,919
2010-12-31 $1,654
2010-09-30 $1,749
2010-06-30 $1,722
2010-03-31 $1,553
2009-12-31 $1,434
2009-09-30 $1,658
2009-06-30 $1,596
2009-03-31 $1,339
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $121.460B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.862B 15.24
Gilead Sciences (GILD) United States $93.974B 12.01
Vertex Pharmaceuticals (VRTX) United States $90.978B 26.81
Regeneron Pharmaceuticals (REGN) United States $90.600B 21.86
CSL (CSLLY) Australia $78.488B 0.00
GSK (GSK) United Kingdom $74.406B 10.09
Seagen (SGEN) United States $39.837B 0.00
Moderna (MRNA) United States $38.162B 37.00
Biogen (BIIB) United States $37.340B 15.88
Argenex SE (ARGX) Netherlands $28.447B 0.00
Horizon Therapeutics Public (HZNP) Ireland $26.492B 25.77
BioNTech SE (BNTX) Germany $24.588B 5.72
Genmab (GMAB) Denmark $23.338B 35.33
Alnylam Pharmaceuticals (ALNY) United States $21.754B 0.00
Illumina (ILMN) United States $20.951B 150.40
BeiGene (BGNE) Cayman Islands $17.836B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.795B 89.25
Incyte (INCY) United States $13.134B 32.03
Exact Sciences (EXAS) United States $12.495B 0.00
Legend Biotech (LEGN) United States $11.111B 0.00
Sarepta Therapeutics (SRPT) United States $10.876B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.868B 30.51
Bio-Techne Corp (TECH) United States $10.763B 38.38
Verona Pharma American Depositary Share (VRNA) United Kingdom $10.501B 0.00
Roivant Sciences (ROIV) United Kingdom $9.685B 0.00
QIAGEN (QGEN) Netherlands $9.049B 19.08
Repligen (RGEN) United States $8.933B 61.15
Exelixis (EXEL) United States $7.129B 43.90
Karuna Therapeutics (KRTX) United States $6.413B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.397B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $5.888B 19.00
Ascendis Pharma (ASND) Denmark $5.427B 0.00
Immunovant (IMVT) United States $5.199B 0.00
Halozyme Therapeutics (HALO) United States $5.165B 17.40
Intra-Cellular Therapies (ITCI) United States $5.161B 0.00
Vaxcyte (PCVX) United States $4.711B 0.00
Alkermes (ALKS) Ireland $4.690B 234.67
Apellis Pharmaceuticals (APLS) United States $4.671B 0.00
Insmed (INSM) United States $3.704B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.632B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.610B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.538B 0.00
Guardant Health (GH) United States $3.538B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.525B 0.00
Axsome Therapeutics (AXSM) United States $3.448B 0.00
Amicus Therapeutics (FOLD) United States $3.405B 0.00
Krystal Biotech (KRYS) United States $3.301B 0.00
Blueprint Medicines (BPMC) United States $3.098B 0.00
Cytokinetics (CYTK) United States $2.957B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.953B 0.00
Denali Therapeutics (DNLI) United States $2.880B 0.00
Intellia Therapeutics (NTLA) United States $2.810B 0.00
Akero Therapeutics (AKRO) United States $2.680B 0.00
Mirati Therapeutics (MRTX) United States $2.658B 0.00
Nuvalent (NUVL) United States $2.655B 0.00
Prothena (PRTA) Ireland $2.612B 0.00
Fortrea Holdings (FTRE) United States $2.545B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.515B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.502B 0.00
Zai Lab (ZLAB) China $2.372B 0.00
Certara (CERT) United States $2.286B 37.66
Xenon Pharmaceuticals (XENE) Canada $2.266B 0.00
Galapagos (GLPG) Belgium $2.252B 0.00
Zealand Pharma (ZLDPF) Denmark $2.164B 0.00
Ventyx Biosciences (VTYX) United States $2.071B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.062B 11.45
Beam Therapeutics (BEAM) United States $1.902B 0.00
Dynavax Technologies (DVAX) United States $1.901B 20.50
Biohaven (BHVN) United States $1.777B 0.00
Arcellx (ACLX) United States $1.763B 0.00
Bavarian Nordic (BVNRY) Denmark $1.697B 10.23
Rocket Pharmaceuticals (RCKT) United States $1.670B 0.00
Vericel (VCEL) United States $1.624B 0.00
NeoGenomics (NEO) United States $1.596B 0.00
IDEAYA Biosciences (IDYA) United States $1.531B 0.00
SpringWorks Therapeutics (SWTX) United States $1.469B 0.00
CureVac (CVAC) Germany $1.455B 0.00
Structure Therapeutics (GPCR) United States $1.434B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.386B 0.00
Myriad Genetics (MYGN) United States $1.375B 0.00
AbCellera Biologics (ABCL) Canada $1.348B 0.00
Arcus Biosciences (RCUS) United States $1.346B 0.00
Celldex Therapeutics (CLDX) United States $1.323B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.316B 0.00
Vir Biotechnology (VIR) United States $1.236B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.222B 32.87
Merus (MRUS) Netherlands $1.220B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.209B 0.00
ANI Pharmaceuticals (ANIP) United States $1.195B 19.12
Twist Bioscience (TWST) United States $1.180B 0.00
89BIO (ETNB) United States $1.165B 0.00
Iovance Biotherapeutics (IOVA) United States $1.130B 0.00
Viking Therapeutics (VKTX) United States $1.122B 0.00
Tango Therapeutics (TNGX) United States $1.107B 0.00
Geron (GERN) United States $1.104B 0.00
MannKind (MNKD) United States $1.103B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.086B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.078B 0.00
Morphic Holding (MORF) United States $1.078B 0.00
Disc Medicine (IRON) United States $1.075B 0.00
Ligand Pharmaceuticals (LGND) United States $1.067B 23.65
Arvinas (ARVN) United States $1.058B 0.00
Apogee Therapeutics (APGE) United States $1.048B 0.00
Revance Therapeutics (RVNC) United States $1.033B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.004B 0.00
Northwest Biotherapeutics (NWBO) United States $0.987B 0.00
Protagonist Therapeutics (PTGX) United States $0.985B 0.00
Pliant Therapeutics (PLRX) United States $0.981B 0.00
Replimune (REPL) United States $0.973B 0.00
ACELYRIN, INC (SLRN) United States $0.972B 0.00
Keros Therapeutics (KROS) United States $0.968B 0.00
Prime Medicine (PRME) United States $0.924B 0.00
MiMedx (MDXG) United States $0.880B 0.00
Belite Bio (BLTE) United States $0.867B 0.00
Pharming Group (PHGUF) Netherlands $0.848B 0.00
Immatics (IMTX) Germany $0.844B 0.00
Pharming Group (PHAR) Netherlands $0.841B 0.00
Cogent Biosciences (COGT) United States $0.838B 0.00
Cytek Biosciences (CTKB) United States $0.826B 0.00
Adaptive Biotechnologies (ADPT) United States $0.803B 0.00
ADMA Biologics Inc (ADMA) United States $0.796B 0.00
Inhibrx (INBX) United States $0.795B 0.00
Kymera Therapeutics (KYMR) United States $0.792B 0.00
Sana Biotechnology (SANA) United States $0.786B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.781B 0.00
REGENXBIO (RGNX) United States $0.777B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.776B 0.00
ImmunityBio (IBRX) United States $0.730B 0.00
POINT Biopharma Global (PNT) United States $0.717B 7.79
Ambrx Biopharma (AMAM) United States $0.695B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.677B 13.39
Novavax (NVAX) United States $0.676B 0.00
Travere Therapeutics (TVTX) United States $0.674B 0.00
Viridian Therapeutics (VRDN) United States $0.662B 0.00
HilleVax (HLVX) United States $0.653B 0.00
Kura Oncology (KURA) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
PureTech Health (PRTC) United States $0.619B 0.00
Vera Therapeutics (VERA) United States $0.615B 0.00
Avid Bioservices (CDMO) United States $0.613B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.608B 0.00
Cabaletta Bio (CABA) United States $0.605B 0.00
Pharma Mar (PHMMF) Spain $0.600B 0.00
Genelux (GNLX) United States $0.593B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
Tyra Biosciences (TYRA) United States $0.587B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.585B 0.00
Allogene Therapeutics (ALLO) United States $0.572B 0.00
WAVE Life Sciences (WVE) Singapore $0.568B 0.00
Editas Medicine (EDIT) United States $0.565B 0.00
Rapt Therapeutics (RAPT) United States $0.561B 0.00
Alector (ALEC) United States $0.561B 0.00
Anavex Life Sciences (AVXL) United States $0.551B 0.00
Entrada Therapeutics (TRDA) United States $0.537B 0.00
Olema Pharmaceuticals (OLMA) United States $0.537B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.530B 0.00
Repare Therapeutics (RPTX) Canada $0.517B 0.00
Avidity Biosciences (RNA) United States $0.486B 0.00
23andMe Holding (ME) United States $0.482B 0.00
Biomea Fusion (BMEA) United States $0.479B 0.00
AnaptysBio (ANAB) United States $0.478B 0.00
IGM Biosciences (IGMS) United States $0.468B 0.00
Castle Biosciences (CSTL) United States $0.466B 0.00
Janux Therapeutics (JANX) United States $0.451B 0.00
Agenus (AGEN) United States $0.425B 0.00
Zymeworks (ZYME) United States $0.424B 2.23
Autolus Therapeutics (AUTL) United Kingdom $0.419B 0.00
Caribou Biosciences (CRBU) United States $0.418B 0.00
Cullinan Oncology (CGEM) United States $0.414B 0.00
Liquidia Technologies (LQDA) United States $0.411B 0.00
Scholar Rock Holding (SRRK) United States $0.410B 0.00
Oculis Holding AG (OCS) Switzerland $0.404B 0.00
ITeos Therapeutics (ITOS) United States $0.401B 0.00
Nurix Therapeutics (NRIX) United States $0.392B 0.00
Icosavax (ICVX) United States $0.390B 0.00
Nautilus Biotechnology (NAUT) United States $0.381B 0.00
Mineralys Therapeutics (MLYS) United States $0.380B 0.00
Aerovate Therapeutics (AVTE) United States $0.379B 0.00
Edgewise Therapeutics (EWTX) United States $0.374B 0.00
Amarin (AMRN) Ireland $0.367B 0.00
Coherus BioSciences (CHRS) United States $0.366B 0.00
Precigen (PGEN) United States $0.363B 0.00
AN2 Therapeutics (ANTX) United States $0.350B 0.00
Aura Biosciences (AURA) United States $0.349B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.343B 0.00
Apollomics (APLM) Taiwan $0.342B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.342B 0.00
Voyager Therapeutics (VYGR) United States $0.339B 3.40
Urogen Pharma (URGN) United States $0.335B 0.00
Arbutus Biopharma (ABUS) United States $0.335B 0.00
Oric Pharmaceuticals (ORIC) United States $0.334B 0.00
MaxCyte (MXCT) United States $0.328B 0.00
UniQure (QURE) Netherlands $0.324B 0.00
Bluebird Bio (BLUE) United States $0.323B 0.00
Seres Therapeutics (MCRB) United States $0.306B 0.00
Erasca (ERAS) United States $0.305B 0.00
Nuvation Bio (NUVB) United States $0.304B 0.00
Humacyte (HUMA) United States $0.302B 0.00
MeiraGTx Holdings (MGTX) United States $0.296B 0.00
Terns Pharmaceuticals (TERN) United States $0.287B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.280B 0.00
Zura Bio (ZURA) United States $0.278B 0.00
Fulcrum Therapeutics (FULC) United States $0.276B 0.00
Anika Therapeutics (ANIK) United States $0.276B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.275B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.269B 0.00
Ovid Therapeutics (OVID) United States $0.266B 0.00
Inozyme Pharma (INZY) United States $0.261B 0.00
DBV Technologies S.A (DBVT) France $0.254B 0.00
Compass Therapeutics (CMPX) United States $0.254B 0.00
Atea Pharmaceuticals (AVIR) United States $0.254B 0.00
ScPharmaceuticals (SCPH) United States $0.251B 0.00
Third Harmonic Bio (THRD) United States $0.251B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.251B 16.15
Y-mAbs Therapeutics (YMAB) United States $0.243B 0.00
AC Immune (ACIU) Switzerland $0.243B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.241B 0.00
Nuvectis Pharma (NVCT) United States $0.238B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.237B 0.00
Renovaro Biosciences (RENB) United States $0.237B 0.00
Kamada (KMDA) Israel $0.235B 18.10
Lifecore Biomedical (LFCR) United States $0.230B 0.00
Immuneering (IMRX) United States $0.229B 0.00
Akoya Biosciences (AKYA) United States $0.228B 0.00
Astria Therapeutics (ATXS) United States $0.226B 0.00
Scilex Holding (SCLX) United States $0.221B 0.00
Inventiva S.A (IVA) France $0.220B 0.00
Gracell Biotechnologies (GRCL) China $0.218B 0.00
Sutro Biopharma (STRO) United States $0.216B 0.00
Fate Therapeutics (FATE) United States $0.215B 0.00
Poseida Therapeutics (PSTX) United States $0.213B 0.00
Innate Pharma S.A (IPHA) France $0.212B 0.00
Praxis Precision Medicines (PRAX) United States $0.212B 0.00
Verastem (VSTM) United States $0.210B 0.00
Vigil Neuroscience (VIGL) United States $0.210B 0.00
Allakos (ALLK) United States $0.209B 0.00
Celcuity (CELC) United States $0.208B 0.00
ALX Oncology Holdings (ALXO) United States $0.204B 0.00
Mesoblast (MESO) Australia $0.204B 0.00
CorMedix Inc (CRMD) United States $0.202B 0.00
Invivyd (IVVD) United States $0.194B 0.00
Sagimet Biosciences (SGMT) United States $0.193B 0.00
TELA Bio (TELA) United States $0.192B 0.00
2seventy Bio (TSVT) United States $0.191B 0.00
Ikena Oncology (IKNA) United States $0.184B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.179B 0.00
Vaxxinity (VAXX) United States $0.177B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.177B 0.00
X4 Pharmaceuticals (XFOR) United States $0.176B 0.00
Gossamer Bio (GOSS) United States $0.176B 0.00
Tenaya Therapeutics (TNYA) United States $0.175B 0.00
Selecta Biosciences (SELB) United States $0.172B 0.00
Emergent Biosolutions (EBS) United States $0.171B 0.00
Applied Therapeutics (APLT) United States $0.169B 0.00
Stoke Therapeutics (STOK) United States $0.167B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.164B 0.00
Prima BioMed (IMMP) Australia $0.164B 0.00
XOMA (XOMA) United States $0.163B 0.00
Oncolytics Biotech (ONCY) Canada $0.160B 0.00
LianBio (LIAN) United States $0.160B 0.00
GENFIT S.A (GNFT) France $0.157B 0.00
PDS Biotechnology (PDSB) United States $0.155B 0.00
Atara Biotherapeutics (ATRA) United States $0.155B 0.00
Adverum Biotechnologies (ADVM) United States $0.155B 0.00
Mersana Therapeutics (MRSN) United States $0.153B 0.00
Molecular Partners AG (MOLN) Switzerland $0.152B 0.00
Ocean Biomedical (OCEA) United States $0.145B 0.00
Trevi Therapeutics (TRVI) United States $0.145B 0.00
Gritstone Bio (GRTS) United States $0.145B 0.00
Vor Biopharma (VOR) $0.143B 0.00
Seer (SEER) United States $0.139B 0.00
Rallybio (RLYB) United States $0.138B 0.00
Graphite Bio (GRPH) United States $0.137B 0.00
Adocia (ADOCY) France $0.135B 0.00
Design Therapeutics (DSGN) United States $0.135B 0.00
InflaRx (IFRX) Germany $0.132B 0.00
Rani Therapeutics Holdings (RANI) United States $0.132B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.131B 0.00
Absci (ABSI) United States $0.128B 0.00
Omega Therapeutics (OMGA) United States $0.127B 0.00
INmune Bio (INMB) United States $0.126B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.126B 0.00
Puma Biotechnology (PBYI) United States $0.126B 0.00
TScan Therapeutics (TCRX) United States $0.125B 0.00
XBiotech (XBIT) United States $0.123B 0.00
Annexon (ANNX) United States $0.122B 0.00
Aadi Bioscience (AADI) United States $0.122B 0.00
PepGen (PEPG) United States $0.121B 0.00
Codexis (CDXS) United States $0.119B 0.00
Theseus Pharmaceuticals (THRX) United States $0.117B 0.00
Greenwich LifeSciences (GLSI) United States $0.113B 0.00
Vaccitech (VACC) United Kingdom $0.112B 0.00
Eton Pharmaceuticals (ETON) United States $0.110B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.107B 0.00
ChromaDex (CDXC) United States $0.106B 0.00
Gamida Cell (GMDA) United States $0.105B 0.00
I-Mab (IMAB) China $0.105B 0.00
Cue Biopharma (CUE) United States $0.104B 0.00
MediciNova (MNOV) United States $0.104B 0.00
Ocugen (OCGN) United States $0.104B 0.00
Bionano Genomics (BNGO) United States $0.103B 0.00
Sangamo Therapeutics (SGMO) United States $0.102B 0.00
Inovio Pharmaceuticals (INO) United States $0.102B 0.00
Opthea (OPT) Australia $0.101B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
PhenomeX (CELL) United States $0.099B 0.00
Immunome (IMNM) United States $0.099B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Abeona Therapeutics (ABEO) United States $0.097B 0.00
Kodiak Sciences (KOD) United States $0.097B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
BRIACELL THERAP (BCTX) Canada $0.093B 0.00
Cara Therapeutics (CARA) United States $0.091B 0.00
Spruce Biosciences (SPRB) United States $0.091B 0.00
ATyr Pharma (LIFE) United States $0.091B 0.00
C4 Therapeutics (CCCC) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
IO Biotech (IOBT) Denmark $0.088B 0.00
NGM Biopharmaceuticals (NGM) United States $0.087B 0.00
Kezar Life Sciences (KZR) United States $0.086B 0.00
BioAtla (BCAB) United States $0.086B 0.00
CytomX Therapeutics (CTMX) United States $0.085B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Turnstone Biologics (TSBX) United States $0.085B 0.00
Cidara Therapeutics (CDTX) United States $0.085B 0.00
Annovis Bio (ANVS) United States $0.084B 0.00
Syros Pharmaceuticals (SYRS) United States $0.082B 0.00
Graf Acquisition IV (GFOR) United States $0.082B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.078B 0.00
Beyond Air (XAIR) United States $0.077B 0.00
Alpha Teknova (TKNO) United States $0.077B 0.00
Werewolf Therapeutics (HOWL) United States $0.076B 0.00
Compugen (CGEN) Israel $0.076B 0.00
Athira Pharma (ATHA) United States $0.076B 0.00
Evelo Biosciences (EVLO) United States $0.075B 0.00
Jasper Therapeutics (JSPR) United States $0.075B 0.00
Nkarta (NKTX) United States $0.074B 0.00
Affimed (AFMD) Germany $0.073B 0.00
Ocuphire Pharma (OCUP) United States $0.073B 4.14
Kronos Bio (KRON) United States $0.073B 0.00
BioXcel Therapeutics (BTAI) United States $0.073B 0.00
Genetron Holdings (GTH) China $0.073B 0.00
Immix Biopharma (IMMX) United States $0.072B 0.00
Elicio Therapeutics (ELTX) United States $0.071B 0.00
G1 Therapeutics (GTHX) United States $0.070B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.069B 0.00
Enzo Biochem (ENZ) United States $0.069B 0.00
HCW Biologics (HCWB) United States $0.069B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.069B 0.00
AVROBIO (AVRO) United States $0.069B 0.00
Shattuck Labs (STTK) United States $0.066B 0.00
Prenetics Global (PRE) Cayman Islands $0.066B 1.55
Eyenovia (EYEN) United States $0.066B 0.00
Kinnate Biopharma (KNTE) United States $0.065B 0.00
Adagene (ADAG) China $0.064B 0.00
Clene (CLNN) United States $0.064B 0.00
Cardiff Oncology (CRDF) United States $0.064B 0.00
Immunic (IMUX) United States $0.064B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.063B 0.00
Adicet Bio (ACET) United States $0.061B 0.00
Xilio Therapeutics (XLO) United States $0.059B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Sorrento Therapeutics (SRNEQ) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.055B 0.00
Dyadic (DYAI) United States $0.054B 0.00
Theratechnologies (THTX) Canada $0.053B 0.00
Instil Bio (TIL) United States $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.052B 0.00
Dianthus Therapeutics (DNTH) United States $0.052B 0.00
HOOKIPA Pharma (HOOK) United States $0.050B 0.00
Solid Biosciences (SLDB) United States $0.050B 0.00
Rezolute (RZLT) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
Longeveron (LGVN) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
OKYO Pharma (OKYO) $0.048B 0.00
Galena Biopharma (SLS) United States $0.047B 0.00
Science 37 Holdings (SNCE) United States $0.047B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.046B 0.00
Curis (CRIS) United States $0.045B 0.00
MiNK Therapeutics (INKT) United States $0.043B 0.00
Celularity (CELU) United States $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.042B 0.00
Cognition Therapeutics (CGTX) United States $0.042B 0.00
Dare Bioscience (DARE) United States $0.041B 0.00
Connect Biopharma Holdings (CNTB) United States $0.041B 0.00
Coya Therapeutics (COYA) United States $0.041B 0.00
Precision BioSciences (DTIL) United States $0.041B 0.00
Portage Biotech (PRTG) $0.040B 0.00
Fortress Biotech (FBIO) United States $0.040B 0.00
Bolt Biotherapeutics (BOLT) United States $0.039B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Mainz Biomed (MYNZ) Germany $0.037B 0.00
Passage Bio (PASG) United States $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.036B 0.00
Neoleukin Therapeutics (NLTX) United States $0.035B 0.00
IN8bio (INAB) United States $0.035B 0.00
UNITY Biotechnology (UBX) United States $0.035B 0.00
Checkpoint Therapeutics (CKPT) United States $0.035B 0.00
Miromatrix Medical (MIRO) United States $0.033B 0.00
Aligos Therapeutics (ALGS) United States $0.032B 0.00
Axcella Health (AXLA) United States $0.031B 0.00
Telesis Bio (TBIO) United States $0.031B 0.00
NuCana (NCNA) United Kingdom $0.031B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.031B 0.00
Kineta (KA) United States $0.030B 0.00
Biora Therapeutics (BIOR) United States $0.030B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.030B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.029B 0.00
BeyondSpring (BYSI) United States $0.029B 0.00
Elevation Oncology (ELEV) United States $0.029B 0.00
Lumos Pharma (LUMO) United States $0.028B 0.00
Bionomics (BNOX) Australia $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.027B 0.00
Candel Therapeutics (CADL) United States $0.027B 0.00
Cyclo Therapeutics (CYTH) United States $0.026B 0.00
Equillium (EQ) United States $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.024B 0.00
Evogene (EVGN) Israel $0.024B 0.00
Forte Biosciences (FBRX) United States $0.024B 0.00
Evaxion Biotech (EVAX) Denmark $0.024B 0.00
Alzamend Neuro (ALZN) United States $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Seelos Therapeutics (SEEL) United States $0.023B 0.00
GENPREX (GNPX) United States $0.023B 0.00
KALA BIO (KALA) United States $0.022B 0.00
Vincerx Pharma (VINC) United States $0.022B 0.00
Elutia (ELUT) United States $0.022B 0.00
TradeUP Acquisition (UPTD) United States $0.022B 0.00
Purple Biotech (PPBT) Israel $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
YS Biopharma (YS) China $0.020B 0.99
Sensei Biotherapeutics (SNSE) United States $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.020B 0.00
Senti Biosciences (SNTI) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Galecto (GLTO) Denmark $0.020B 0.00
Medicenna Therapeutics (MDNA) Canada $0.019B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.019B 0.00
Catalyst Biosciences (CBIO) United States $0.019B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.019B 0.00
Virios Therapeutics (VIRI) United States $0.018B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.018B 0.00
Acorda Therapeutics (ACOR) United States $0.018B 0.00
Vascular Biogenics (VBLT) Israel $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Mustang Bio (MBIO) United States $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
AquaBounty Technologies (AQB) United States $0.016B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.016B 0.00
CalciMedica (CALC) United States $0.015B 0.00
VBI Vaccines (VBIV) United States $0.015B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
Aprea Therapeutics (APRE) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Genetic Technologies (GENE) Australia $0.015B 0.00
RenovoRx (RNXT) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Frequency Therapeutics (FREQ) United States $0.014B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.013B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.013B 0.00
Senesco Technologies (ELOX) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
TFF Pharmaceuticals (TFFP) United States $0.013B 0.00
ZIVO Bioscience (ZIVO) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
Cingulate (CING) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.011B 0.00
Atreca (BCEL) United States $0.011B 0.00
Talis Biomedical (TLIS) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
ARAVIVE, INC (ARAV) United States $0.010B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.009B 0.00
Avalon GloboCare (ALBT) United States $0.009B 0.00
Imunon (IMNN) United States $0.009B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.009B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.009B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
Cohbar (CWBR) United States $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Blue Water Biotech (BWV) United States $0.008B 0.00
Sunshine Biopharma (SBFM) Canada $0.008B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.008B 0.00
Monopar Therapeutics (MNPR) United States $0.008B 0.00
Athersys (ATHX) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Lexaria Bioscience (LEXX) Canada $0.008B 0.00
Benitec Biopharma (BNTC) United States $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Biorestorative Therapies (BRTX) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Kintara Therapeutics (KTRA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Biophytis SA (BPTS) France $0.007B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.007B 0.00
Applied Molecular Transport (AMTI) United States $0.007B 0.00
CervoMed (CRVO) United States $0.007B 0.00
Exicure (XCUR) United States $0.006B 0.43
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Panbela Therapeutics (PBLA) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.04
Aptevo Therapeutics (APVO) United States $0.004B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.25
Aceragen (ACGN) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
First Wave BioPharma (FWBI) United States $0.002B 0.06
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 15.79
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Synlogic (SYBX) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00